Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation

被引:83
作者
Câmara, NOS [1 ]
Sebille, F [1 ]
Lechler, RI [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll London, Dept Immunol, Div Med, London W12 0NN, England
关键词
regulatory cells; CD8 T cell activation; immunoregulation;
D O I
10.1002/eji.200323966
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Amongst the many types of regulatory cells that have been described during the past few years, the spontaneously occurring population that is characterized by co-expression of CD4 and CD25 appears to play a key role in the prevention of autoimmunity and the maintenance of transplantation tolerance. In this study we have examined the ability of CD4(+)CD25(+) T cells to regulate human CD8(+) T cells, and the behavior of CD8(+) T cells following activation in the presence of regulatory CD4(+)CD25(+) T cells. The experiments described here demonstrate that human CD4(+)CD25(+) T cells cause pronounced and sustained inhibition of CD8(+) T cell proliferation in response to polyclonal and allogeneic stimulation. The regulation of CD8(+) T cell activation was cell contact-dependent and included inhibition of perforin, granzyme B and IFN-gamma cytokine production at the transcriptional level and impaired cytotoxicity. The regulated CD8(+) T cell population showed sustained hyporesponsiveness and refractoriness to exogenous IL-2. These data provide insights into the short- and long-term effects of CD4(+)CD25(+) T cells on CD8(+) T cells that could be of considerable value in optimizing vaccination against tumor and viral antigens.
引用
收藏
页码:3473 / 3483
页数:11
相关论文
共 41 条
[1]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[2]   B cells and professional APCs recruit regulatory T cells via CCL4 [J].
Bystry, RS ;
Aluvihare, V ;
Welch, KA ;
Kallikourdis, M ;
Betz, AG .
NATURE IMMUNOLOGY, 2001, 2 (12) :1126-1132
[3]  
Chai JG, 2002, EUR J IMMUNOL, V32, P2365, DOI 10.1002/1521-4141(200208)32:8<2365::AID-IMMU2365>3.0.CO
[4]  
2-2
[5]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[6]   Human CD4+CD25+ regulatory, contact-dependent T cells induce interleukin 1-producing, contact-independent type 1-like regulatory T cells [J].
Dieckmann, D ;
Bruett, CH ;
Ploettner, H ;
Lutz, MB ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (02) :247-253
[7]   Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood [J].
Dieckmann, D ;
Plottner, H ;
Berchtold, S ;
Berger, T ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1303-1310
[8]   CD4+CD25+ cells regulate CD8 cell anergy in neonatal tolerant mice [J].
Gao, QL ;
Rouse, TM ;
Kazmerzak, K ;
Field, EH .
TRANSPLANTATION, 1999, 68 (12) :1891-1897
[9]   IL-30 is required for regulatory T cells to mediate tolerance to alloantigens in vivo [J].
Hara, M ;
Kingsley, CI ;
Niimi, M ;
Read, S ;
Turvey, SE ;
Bushell, AR ;
Morris, PJ ;
Powrie, F ;
Wood, KJ .
JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :3789-3796
[10]   The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice [J].
Hong, S ;
Wilson, MT ;
Serizawa, I ;
Wu, L ;
Singh, N ;
Naidenko, OV ;
Miura, T ;
Haba, T ;
Scherer, DC ;
Wei, J ;
Kronenberg, M ;
Koezuka, Y ;
Van Kaer, L .
NATURE MEDICINE, 2001, 7 (09) :1052-1056